Clinical Features and Prevalence of Spondyloarthritis in a Cohort of Italian Patients Presenting with Acute Nongranulomatous Anterior Uveitis.


Journal

Journal of immunology research
ISSN: 2314-7156
Titre abrégé: J Immunol Res
Pays: Egypt
ID NLM: 101627166

Informations de publication

Date de publication:
2022
Historique:
received: 31 12 2020
revised: 02 11 2021
accepted: 24 12 2021
entrez: 28 1 2022
pubmed: 29 1 2022
medline: 30 3 2022
Statut: epublish

Résumé

To describe the clinical features of acute nongranulomatous anterior uveitis (NGAU) patients and to estimate the prevalence of concomitant spondyloarthritis (SpA). Retrospective study of consecutive patients affected by NGAU referred to the Ocular Immunology Unit of the AUSL-IRCCS di Reggio Emilia, Italy, between January 2016 and January 2019. All patients underwent ophthalmic evaluation and blood test with HLA-B27 typing and were referred to a rheumatologist to identify any undiagnosed SpA. SpA was classified according to the Assessment of SpondyloArthritis international Society (ASAS) criteria in axial or peripheral SpA. Patients were divided into two groups: NGAU with associated SpA (SpA+) and NGAU without SpA (SpA-). Clinical and demographic features of the two groups, including sex, HLA-B27, family history of rheumatic disease, uveitis laterality, course, and severity of ocular inflammation, complications, and treatment, were compared. Ninety-nine patients with NGAU were enrolled, of whom 36 (36%) with a diagnosis of SpA: 14 with peripheral SpA and 22 with axial SpA. The prevalence of SpA was higher in HLA-B27-positive patients than in HLA-B27-negative patients (50% vs. 15%, Our results confirmed the high prevalence of undiagnosed SpA in patients with NGAU, suggesting that, regardless of HLA-B27 status, in the presence of IBP and/or peripheral arthritis, patients with NGAU must be referred to the rheumatologist to allow earlier diagnosis.

Identifiants

pubmed: 35087912
doi: 10.1155/2022/6632081
pmc: PMC8789471
doi:

Substances chimiques

HLA-B27 Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6632081

Informations de copyright

Copyright © 2022 Elena Bolletta et al.

Déclaration de conflit d'intérêts

All authors certify that they have no affiliations or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript.

Références

Middle East Afr J Ophthalmol. 2009 Oct;16(4):159-67
pubmed: 20404984
RMD Open. 2018 Feb 24;4(1):e000553
pubmed: 29531779
Rheumatology (Oxford). 2021 Apr 6;60(4):1620-1628
pubmed: 33428758
Ann Rheum Dis. 2009 Jun;68(6):777-83
pubmed: 19297344
Joint Bone Spine. 2017 Jul;84(4):467-471
pubmed: 27450199
Ther Adv Musculoskelet Dis. 2020 Sep 12;12:1759720X20951733
pubmed: 32963592
Acta Ophthalmol Scand. 2001 Feb;79(1):64-8
pubmed: 11167291
Ann Rheum Dis. 2015 Nov;74(11):1990-5
pubmed: 24928841
Clin Rheumatol. 2015 Aug;34(8):1397-405
pubmed: 25185731
Int Ophthalmol. 2018 Feb;38(1):133-142
pubmed: 28070744
J Rheumatol. 1977 Autumn;4(3):277-81
pubmed: 144796
Am J Ophthalmol. 2005 Sep;140(3):509-16
pubmed: 16196117
Clin Rheumatol. 2009 Mar;28(3):327-31
pubmed: 19052836
Ocul Immunol Inflamm. 2002 Dec;10(4):263-79
pubmed: 12854035
Rheumatol Int. 2018 Sep;38(9):1727-1734
pubmed: 29961101
Ann Rheum Dis. 2009 Jun;68(6):770-6
pubmed: 19297345
Ophthalmologica. 1996;210(4):234-8
pubmed: 8841072
Ophthalmology. 2016 Aug;123(8):1632-1636
pubmed: 27084561
Ophthalmology. 2010 Feb;117(2):366-72
pubmed: 20006905
Ophthalmology. 1998 Sep;105(9):1646-51
pubmed: 9754172
Br J Ophthalmol. 1984 Oct;68(10):741-5
pubmed: 6236842
Surv Ophthalmol. 2005 Jul-Aug;50(4):364-88
pubmed: 15967191

Auteurs

Elena Bolletta (E)

Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Pierluigi Macchioni (P)

Rheumatology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Giorgia Citriniti (G)

Rheumatology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Valentina Mastrofilippo (V)

Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Raffaella Aldigeri (R)

Department of Medicine and Surgery, University of Parma, Parma, Italy.

Luca De Simone (L)

Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Fabrizio Gozzi (F)

Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Chantal Adani (C)

Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Anna Sangiovanni (A)

Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Chiara Posarelli (C)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.

Michele Figus (M)

Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa, Italy.

Francesco Muratore (F)

Rheumatology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Nicolò Pipitone (N)

Rheumatology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.

Carlo Salvarani (C)

Rheumatology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.
Department of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Luca Cimino (L)

Ocular Immunology Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.
Department of Surgery, Medicine, Dentistry and Morphological Sciences, with Interest in Transplants, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH